WO2004087924A3 - Method for delivery of substances to intracellular microorganisms - Google Patents

Method for delivery of substances to intracellular microorganisms Download PDF

Info

Publication number
WO2004087924A3
WO2004087924A3 PCT/EP2004/003414 EP2004003414W WO2004087924A3 WO 2004087924 A3 WO2004087924 A3 WO 2004087924A3 EP 2004003414 W EP2004003414 W EP 2004003414W WO 2004087924 A3 WO2004087924 A3 WO 2004087924A3
Authority
WO
WIPO (PCT)
Prior art keywords
intracellular microorganisms
substances
delivery
invention concerns
microorganisms
Prior art date
Application number
PCT/EP2004/003414
Other languages
French (fr)
Other versions
WO2004087924A2 (en
Inventor
Thomas F Meyer
Agnieszka Szczepek
Hesham Al-Younes
Dagmar Heuer
Michael Dittrich
Original Assignee
Max Planck Gesellschaft
Thomas F Meyer
Agnieszka Szczepek
Hesham Al-Younes
Dagmar Heuer
Michael Dittrich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft, Thomas F Meyer, Agnieszka Szczepek, Hesham Al-Younes, Dagmar Heuer, Michael Dittrich filed Critical Max Planck Gesellschaft
Publication of WO2004087924A2 publication Critical patent/WO2004087924A2/en
Publication of WO2004087924A3 publication Critical patent/WO2004087924A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)

Abstract

The present invention concerns a method of delivering substances to obligate intracellular microorganisms. Further, the invention concerns a method of treatment of infections of intracellular microorganisms. Further, the invention concerns substances suitable for treatment of infections of intracellular microorganisms. In addition, the invention concerns stable transformants of obligate intracellular microorganisms.
PCT/EP2004/003414 2003-03-31 2004-03-31 Method for delivery of substances to intracellular microorganisms WO2004087924A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03006900 2003-03-31
EP03006900.9 2003-03-31

Publications (2)

Publication Number Publication Date
WO2004087924A2 WO2004087924A2 (en) 2004-10-14
WO2004087924A3 true WO2004087924A3 (en) 2005-05-26

Family

ID=33104040

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/003414 WO2004087924A2 (en) 2003-03-31 2004-03-31 Method for delivery of substances to intracellular microorganisms

Country Status (1)

Country Link
WO (1) WO2004087924A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027105A2 (en) * 1997-11-21 1999-06-03 Genset Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
WO2000061190A2 (en) * 1999-04-09 2000-10-19 Microbiological Research Authority Treatment of intracellular infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027105A2 (en) * 1997-11-21 1999-06-03 Genset Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
WO2000061190A2 (en) * 1999-04-09 2000-10-19 Microbiological Research Authority Treatment of intracellular infection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CONANT STEPHANIE B ET AL: "MHC class II peptide flanking residues of exogenous antigens influence recognition by autoreactive T cells.", AUTOIMMUNITY REVIEWS. JAN 2003, vol. 2, no. 1, January 2003 (2003-01-01), pages 8 - 12, XP002302307, ISSN: 1568-9972 *
DATABASE Geneseq [online] 13 September 1999 (1999-09-13), "Chlamydia pneumoniae transmembrane protein sequence.", XP002302309, retrieved from EBI accession no. GSN:AAY34719 Database accession no. AAY34719 *
KALMAN S ET AL: "COMPARATIVE GENOMES OF CHLAMYDIA PNEUMONIAE AND C. TRACHOMATIS", NATURE GENETICS, NEW YORK, NY, US, vol. 21, no. 4, April 1999 (1999-04-01), pages 385 - 389, XP000853883, ISSN: 1061-4036 *
LENZ D C ET AL: "A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 AUG 2001, vol. 167, no. 3, 1 August 2001 (2001-08-01), pages 1803 - 1808, XP002302308, ISSN: 0022-1767 *

Also Published As

Publication number Publication date
WO2004087924A2 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
WO2004014143A8 (en) Compositions and process for delivering an additive
AU2003304420A1 (en) Compositions, methods, apparatuses, and systems for singlet oxygen delivery
WO2006031857A3 (en) Delivering iron to an animal
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2007059202A3 (en) Pyrazolyl urea derivatives useful in the treatment of cancer
TW200738270A (en) Method of treating depression using a TNFα antibody
WO2006117228A3 (en) Ophthalmic devices for sustained delivery of active compounds
AP2005003452A0 (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors.
IL190646A (en) Multi-functional ionic liquid compositions comprising active pharmaceutical, biological, nutritional and energetic ingredients and method for producing the same
WO2007087113A3 (en) Natural antisense and non-coding rna transcripts as drug targets
WO2005117557A3 (en) Expression system
MX2007002189A (en) Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery.
WO2007143086A3 (en) Delivery method
WO2006138709A3 (en) Lkktet and/or lkktnt peptide compositions and methods
WO2005108428A3 (en) Cd40 splice variants and their uses
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2007075870A3 (en) Processes for taxane derivatives and intermediates useful therein
ZA200406944B (en) Method of deflavoring soy-derived materials for use in beverages.
TW200626162A (en) Agent for controlling demodicosis
WO2006036817A3 (en) Fungal variants and uses thereof
WO2004091368A3 (en) Sea buckthorn compositions and associated methods
WO2006047728A3 (en) Bmp gene and fusion protein
WO2006133055A3 (en) Method and composition for increasing the alkalinity of the body
WO2007098924A3 (en) Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
MX2010001092A (en) Stable liquid pharmaceutical composition based on trazodone.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase